← Open Payments lookup

KRISTINE MOLLOHAN: Open Payments

NPI 1801213301 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$631 in 38 payments from 11 companies in 2025. Trend: 2023 $943 · 2024 $638 · 2025 $631

Food & beverage: $631
CompanyPaymentsAmount
ABBVIE INC.18$170
Vanda Pharmaceuticals Inc.4$118
AstraZeneca Pharmaceuticals LP4$103
Xeris Pharmaceuticals, Inc.2$45
PFIZER INC.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Alkermes, Inc.1$28
Amgen Inc.2$28
Bayer Healthcare Pharmaceuticals Inc.1$26
Lundbeck LLC1$25

Products named: FANAPT, FARXIGA, VRAYLAR, UBRELVY, QULIPTA, RECORLEV, CAPLYTA, VIVITROL.

Industry payments across AL — which companies pay providers there.